• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原癌基因HER-2在正常、发育异常及肿瘤性猫乳腺组织中的表达:一项免疫组织化学及显色原位杂交研究

Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study.

作者信息

Ordás Javier, Millán Yolanda, Dios Rafaela, Reymundo Carlos, de Las Mulas Juana Martín

机构信息

Departamento de Anatomía Patológica Comparada, Facultad de Veterinaria, Universidad de Córdoba, Campus Universitario de Rabanales, Carretera de Madrid- Cádiz Km 396 14014 Córdoba, Spain.

出版信息

BMC Cancer. 2007 Sep 20;7:179. doi: 10.1186/1471-2407-7-179.

DOI:10.1186/1471-2407-7-179
PMID:17880730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2045669/
Abstract

BACKGROUND

Feline mammary carcinoma has been proposed as a natural model of highly aggressive, hormone-independent human breast cancer. To further explore the utility of the model by adding new similarities between the two diseases, we have analyzed the oncogene HER-2 status at both the protein and the gene levels.

METHODS

Formalin-fixed, paraffin-embedded tissue samples from 30 invasive carcinomas, 7 benign lesions and two normal mammary glands were analyzed. Tumour features with prognostic value were recorded. The expression of protein HER-2 was analyzed by immunohistochemistry and the number of gene copies by means of DNA chromogenic in situ hybridization.

RESULTS

Immunohistochemical HER-2 protein overexpression was found in 40% of feline mammary carcinomas, a percentage higher to that observed in human breast carcinoma. As in women, feline tumours with HER-2 protein overexpression had pathological features of high malignancy. However, amplification of HER-2 was detected in 16% of carcinomas with protein overexpression, a percentage much lower than that observed in their human counterpart.

CONCLUSION

Feline mammary carcinoma would be a suitable natural model of that subset of human breast carcinomas with HER-2 protein overexpression without gene amplification.

摘要

背景

猫乳腺肿瘤已被视为极具侵袭性、激素非依赖性人类乳腺癌的自然模型。为通过增加两种疾病之间的新相似性进一步探索该模型的效用,我们在蛋白质和基因水平分析了癌基因HER-2的状态。

方法

分析了30例浸润性癌、7例良性病变及两个正常乳腺的福尔马林固定、石蜡包埋组织样本。记录具有预后价值的肿瘤特征。通过免疫组织化学分析蛋白质HER-2的表达,并通过DNA显色原位杂交分析基因拷贝数。

结果

40%的猫乳腺癌中发现免疫组织化学HER-2蛋白过表达,该比例高于人类乳腺癌中的观察值。与女性情况一样,HER-2蛋白过表达的猫肿瘤具有高恶性的病理特征。然而,在16%蛋白过表达的癌中检测到HER-2扩增,该比例远低于人类相应肿瘤中的观察值。

结论

猫乳腺癌将是人类乳腺癌中HER-2蛋白过表达但无基因扩增这一亚组的合适自然模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7151/2045669/b8453c86c748/1471-2407-7-179-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7151/2045669/24e9cd482a27/1471-2407-7-179-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7151/2045669/15ba4940f4e9/1471-2407-7-179-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7151/2045669/b8453c86c748/1471-2407-7-179-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7151/2045669/24e9cd482a27/1471-2407-7-179-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7151/2045669/15ba4940f4e9/1471-2407-7-179-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7151/2045669/b8453c86c748/1471-2407-7-179-3.jpg

相似文献

1
Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study.原癌基因HER-2在正常、发育异常及肿瘤性猫乳腺组织中的表达:一项免疫组织化学及显色原位杂交研究
BMC Cancer. 2007 Sep 20;7:179. doi: 10.1186/1471-2407-7-179.
2
Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.犬乳腺肿瘤中癌基因HER-2的免疫组化及显色原位杂交研究
Breast Cancer Res Treat. 2003 Aug;80(3):363-7. doi: 10.1023/a:1024929730165.
3
Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.HER-2在猫浸润性乳腺癌中的过表达:一项免疫组织化学调查及其预后潜力评估
Vet Pathol. 2005 Jan;42(1):30-4. doi: 10.1354/vp.42-1-30.
4
Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.正常、发育异常及肿瘤性犬猫乳腺组织中类固醇受体表达的比较。
Res Vet Sci. 2005 Dec;79(3):225-32. doi: 10.1016/j.rvsc.2005.02.002. Epub 2005 Apr 7.
5
HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.犬形态正常、增生和肿瘤性乳腺组织中 HER-2 的表达及其与临床结果的相关性。
Res Vet Sci. 2013 Apr;94(2):299-305. doi: 10.1016/j.rvsc.2012.09.016. Epub 2012 Nov 7.
6
HER2 Amplification Status in Feline Mammary Carcinoma: A Tissue Microarray-Fluorescence In Situ Hydridization-Based Study.猫乳腺肿瘤中HER2基因扩增状态:一项基于组织芯片-荧光原位杂交的研究
Vet Pathol. 2019 Mar;56(2):230-238. doi: 10.1177/0300985818808531. Epub 2018 Nov 1.
7
An Immunohistochemical study of HER-2 expression in feline mammary tumours.猫乳腺肿瘤中HER-2表达的免疫组织化学研究。
J Comp Pathol. 2011 Feb-Apr;144(2-3):170-9. doi: 10.1016/j.jcpa.2010.08.010. Epub 2010 Sep 28.
8
Feline HER2 protein expression levels and gene status in feline mammary carcinoma: optimization of immunohistochemistry (IHC) and in situ hybridization (ISH) techniques.猫科动物 HER2 蛋白表达水平和基因状态在猫科动物乳腺肿瘤中的研究:免疫组织化学(IHC)和原位杂交(ISH)技术的优化。
Microsc Microanal. 2013 Aug;19(4):876-82. doi: 10.1017/S1431927613001529. Epub 2013 May 30.
9
Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.异常的P-钙黏蛋白表达与侵袭性猫乳腺癌相关。
BMC Vet Res. 2014 Nov 26;10:270. doi: 10.1186/s12917-014-0270-z.
10
Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.乳腺癌中Her-2/Neu状态的测定:免疫组织化学与荧光原位杂交的比较分析
Mod Pathol. 2000 Jan;13(1):37-45. doi: 10.1038/modpathol.3880007.

引用本文的文献

1
Unveiling HER2 immunoexpression in canine hepatoid gland neoplasms: clinicopathological and morphological associations.揭示犬类肝样腺肿瘤中HER2免疫表达:临床病理与形态学关联
Int J Vet Sci Med. 2025 Apr 24;13(1):1-12. doi: 10.1080/23144599.2025.2495522. eCollection 2025.
2
Immunohistochemical Expression and Prognostic Value of COX-2 and Alpha-Smooth Muscle Actin-positive Cancer-associated Fibroblasts in Feline Mammary Cancer.猫乳腺肿瘤中 COX-2 和 Alpha-Smooth Muscle Actin 阳性癌相关成纤维细胞的免疫组化表达及其预后价值。
In Vivo. 2024 Mar-Apr;38(2):598-605. doi: 10.21873/invivo.13478.
3
A Scoping Review on Tyrosine Kinase Inhibitors in Cats: Current Evidence and Future Directions.

本文引用的文献

1
Immunohistochemical detection of HER-2/neu expression in spontaneous feline mammary tumours.自发猫乳腺肿瘤中HER-2/neu表达的免疫组织化学检测
Vet Comp Oncol. 2005 Mar;3(1):8-15. doi: 10.1111/j.1476-5810.2005.00063.x.
2
Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.自发性猫乳腺癌是HER2过表达的预后不良人类乳腺癌的一种模型。
Cancer Res. 2005 Feb 1;65(3):907-12.
3
Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
猫酪氨酸激酶抑制剂的范围综述:当前证据与未来方向
Animals (Basel). 2023 Sep 29;13(19):3059. doi: 10.3390/ani13193059.
4
ERBB Receptors and Their Ligands in the Developing Mammary Glands of Different Species: Fifteen Characters in Search of an Author.不同物种乳腺发育过程中 ERBB 受体及其配体:十五个特征探寻作者。
J Mammary Gland Biol Neoplasia. 2023 May 23;28(1):10. doi: 10.1007/s10911-023-09538-w.
5
HER2, PR, ER, Ki-67 and Cytokeratin 5/6 Expression in Benign Feline Mammary Lesions.HER2、PR、ER、Ki-67和细胞角蛋白5/6在猫乳腺良性病变中的表达
Animals (Basel). 2022 Jun 21;12(13):1599. doi: 10.3390/ani12131599.
6
Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival.分析拷贝数变异与猫乳腺肿瘤生存。
Sci Rep. 2020 Jan 22;10(1):1003. doi: 10.1038/s41598-020-57942-7.
7
Assessment of and gene status and expression profile in feline mammary tumors: findings and guidelines.猫乳腺肿瘤中 和 基因状态及表达谱的评估:研究结果与指南
Aging (Albany NY). 2019 Jul 12;11(13):4688-4705. doi: 10.18632/aging.102079.
8
Serum SDF-1 levels are a reliable diagnostic marker of feline mammary carcinoma, discriminating HER2-overexpressing tumors from other subtypes.血清基质细胞衍生因子-1水平是猫乳腺癌的可靠诊断标志物,可将HER2过表达肿瘤与其他亚型区分开来。
Oncotarget. 2017 Nov 11;8(62):105775-105789. doi: 10.18632/oncotarget.22398. eCollection 2017 Dec 1.
9
Cat Mammary Tumors: Genetic Models for the Human Counterpart.猫乳腺肿瘤:人类对应物的遗传模型
Vet Sci. 2016 Aug 16;3(3):17. doi: 10.3390/vetsci3030017.
10
HER2-positive feline mammary carcinoma.人表皮生长因子受体2阳性猫乳腺癌
Aging (Albany NY). 2016 Aug;8(8):1574-5. doi: 10.18632/aging.101015.
HER-2在猫浸润性乳腺癌中的过表达:一项免疫组织化学调查及其预后潜力评估
Vet Pathol. 2005 Jan;42(1):30-4. doi: 10.1354/vp.42-1-30.
4
c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors.犬乳腺肿瘤中c-erbB-2表达与细胞核多形性
Braz J Med Biol Res. 2004 Nov;37(11):1673-81. doi: 10.1590/s0100-879x2004001100013. Epub 2004 Oct 26.
5
Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization.通过显色原位杂交和荧光原位杂交检测HER-2癌基因扩增的实验室间比较。
Clin Cancer Res. 2004 Jul 15;10(14):4793-8. doi: 10.1158/1078-0432.CCR-0428-03.
6
Targeted therapy in breast cancer: the HER-2/neu gene and protein.乳腺癌的靶向治疗:HER-2/neu基因与蛋白
Mol Cell Proteomics. 2004 Apr;3(4):379-98. doi: 10.1074/mcp.R400001-MCP200. Epub 2004 Feb 3.
7
Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.犬乳腺肿瘤中癌基因HER-2的免疫组化及显色原位杂交研究
Breast Cancer Res Treat. 2003 Aug;80(3):363-7. doi: 10.1023/a:1024929730165.
8
Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status.正常、发育异常和肿瘤性猫乳腺中的孕激素受体。与雌激素受体状态的比较。
Res Vet Sci. 2002 Apr;72(2):153-61. doi: 10.1053/rvsc.2001.0542.
9
Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.显色原位杂交:检测存档乳腺癌样本中HER-2/neu癌基因扩增的荧光原位杂交实用替代方法。
Am J Pathol. 2000 Nov;157(5):1467-72. doi: 10.1016/S0002-9440(10)64785-2.
10
Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer.HER-2/neu(cerbB-2)在乳腺癌中的生物学及临床意义。
Adv Anat Pathol. 2000 May;7(3):158-66. doi: 10.1097/00125480-200007030-00005.